Deciphering signaling networks in osteosarcoma pathobiology
نویسندگان
چکیده
منابع مشابه
Deciphering Phosphotyrosine-Dependent Signaling Networks in Cancer by SH2 Profiling.
It has been a decade since the introduction of SH2 profiling, a modular domain-based molecular diagnostics tool. This review covers the original concept of SH2 profiling, different analytical platforms, and their applications, from the detailed analysis of single proteins to broad screening in translational research. Illustrated by practical examples, we discuss the uniqueness and advantages of...
متن کاملWnt signaling in osteosarcoma.
Osteosarcoma (OS) is the most common primary bone malignancy diagnosed in children and adolescents with a high propensity for local invasion and distant metastasis. Despite current multidisciplinary treatments, there has not been a drastic change in overall prognosis within the last two decades. With current treatments, 60-70 % of patients with localized disease survive. Given a propensity of W...
متن کاملDeciphering metabolic networks.
All higher organisms divide major biochemical steps into different cellular compartments and often use tissue-specific division of metabolism for the same purpose. Such spatial resolution is accompanied with temporal changes of metabolite synthesis in response to environmental stimuli or developmental needs. Although analyses of primary and secondary gene products, i.e. transcripts, proteins, a...
متن کاملDeciphering cell signaling rewiring in human disorders
3 PREFACE 5 INTRODUCTION 6 ALZHEIMER’S DISEASE: A DISORDER OF PROTEIN MISFOLDING AND SYNAPTIC FAILURE 7 CANCER: A SYSTEMS BIOLOGY DISORDER 7 1. MOLECULAR MECHANISMS OF NEURODEGENERATION 12 CHAPTER AT GLANCE 12 1.1 PHOSPHORYLATION CASCADES AND OXIDATIVE STRESS RESPONSE IN NEURODEGENERATIVE DISEASES ...
متن کاملUnderstanding the Osteosarcoma Pathobiology: A Comparative Oncology Approach
Osteosarcoma is an aggressive primary bone tumor in humans and is among the most common cancer afflicting dogs. Despite surgical advancements and intensification of chemo- and targeted therapies, the survival outcome for osteosarcoma patients is, as of yet, suboptimal. The presence of metastatic disease at diagnosis or its recurrence after initial therapy is a major factor for the poor outcomes...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Experimental Biology and Medicine
سال: 2016
ISSN: 1535-3702,1535-3699
DOI: 10.1177/1535370216648806